Serratus anterior and pectoralis plane blocks for robotically assisted mitral valve repair : a randomised clinical trial

Copyright © 2023 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved..

BACKGROUND: Minimally invasive cardiac surgery provokes substantial pain and therefore analgesic consumption. The effect of fascial plane blocks on analgesic efficacy and overall patient satisfaction remains unclear. We therefore tested the primary hypothesis that fascial plane blocks improve overall benefit analgesia score (OBAS) during the initial 3 days after robotically assisted mitral valve repair. Secondarily, we tested the hypotheses that blocks reduce opioid consumption and improve respiratory mechanics.

METHODS: Adults scheduled for robotically assisted mitral valve repairs were randomised to combined pectoralis II and serratus anterior plane blocks or to routine analgesia. The blocks were ultrasound-guided and used a mixture of plain and liposomal bupivacaine. OBAS was measured daily on postoperative Days 1-3 and were analysed with linear mixed effects modelling. Opioid consumption was assessed with a simple linear regression model and respiratory mechanics with a linear mixed model.

RESULTS: As planned, we enrolled 194 patients, with 98 assigned to blocks and 96 to routine analgesic management. There was neither time-by-treatment interaction (P=0.67) nor treatment effect on total OBAS over postoperative Days 1-3 with a median difference of 0.08 (95% confidence interval [CI]: -0.50 to 0.67; P=0.69) and an estimated ratio of geometric means of 0.98 (95% CI: 0.85-1.13; P=0.75). There was no evidence of a treatment effect on cumulative opioid consumption or respiratory mechanics. Average pain scores on each postoperative day were similarly low in both groups.

CONCLUSIONS: Serratus anterior and pectoralis plane blocks did not improve postoperative analgesia, cumulative opioid consumption, or respiratory mechanics during the initial 3 days after robotically assisted mitral valve repair.

CLINICAL TRIAL REGISTRATION: NCT03743194.

Errataetall:

CommentIn: Br J Anaesth. 2023 Aug;131(2):e49-e50. - PMID 37271722

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:130

Enthalten in:

British journal of anaesthesia - 130(2023), 6 vom: 11. Juni, Seite 786-794

Sprache:

Englisch

Beteiligte Personen:

Alfirevic, Andrej [VerfasserIn]
Marciniak, Donn [VerfasserIn]
Duncan, Andra E [VerfasserIn]
Kelava, Marta [VerfasserIn]
Yalcin, Esra Kutlu [VerfasserIn]
Hamadnalla, Hassan [VerfasserIn]
Pu, Xuan [VerfasserIn]
Sessler, Daniel I [VerfasserIn]
Bauer, Andrew [VerfasserIn]
Hargrave, Jennifer [VerfasserIn]
Bustamante, Sergio [VerfasserIn]
Gillinov, Marc [VerfasserIn]
Wierup, Per [VerfasserIn]
Burns, Daniel J P [VerfasserIn]
Lam, Louis [VerfasserIn]
Turan, Alparslan [VerfasserIn]

Links:

Volltext

Themen:

Analgesia
Analgesics
Analgesics, Opioid
Cardiac anaesthesia
Fascial muscle plane blocks
Journal Article
Minimally invasive cardiac surgery
Mitral valve repair
Pain
Randomized Controlled Trial

Anmerkungen:

Date Completed 19.05.2023

Date Revised 27.10.2023

published: Print-Electronic

ClinicalTrials.gov: NCT03743194

CommentIn: Br J Anaesth. 2023 Aug;131(2):e49-e50. - PMID 37271722

Citation Status MEDLINE

doi:

10.1016/j.bja.2023.02.038

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM355596121